Marking what it considers the growing adoption of the personal use of exoskeletons, ReWalk Robotics Ltd notes that it has reached a milestone by recently selling its 100th exoskeleton.
The Israel-based, Marlborough, Mass-headquartered company states in a media release that it has also sold more than 150 exoskeleton systems to rehabilitation centers.
“This milestone symbolizes a new era for ReWalk. More public and private insurers are willing to procure and reimburse systems, the technology is evolving at a rapid pace, and there is a growing wealth of clinical evidence outlining the benefits of the technology to the health and well-being of the user,” said ReWalk Robotics CEO Larry Jasinski, in the release.
The FDA-cleared ReWalk Robotics Personal 6.0 wearable robotic exoskeleton is engineered to provide powered hip and knee motion to help enable individuals with spinal cord injury to stand upright and walk.
Rick Batty, a Madison, Wis, resident who uses the ReWalk system, states in the release that it helped him to stand and walk again after becoming paralyzed from the waist down after a stroke.
“The technology also helped me achieve a dramatic turnaround in my everyday health, increasing my upper-body strength and flexibility, and I continue to experience improvements with regular use,” he adds.
[Source(s): ReWalk Robotics Ltd, PR Newswire]
